Major depressive disorder (MDD) shows a large heterogeneity in antidepressant treatment outcome, a variability explained in part by common-variant liability captured by polygenic scores (PGSs). We performed a review of PubMed- and Google Scholar-indexed studies that related any PGS to treatment response, remission or resistance in adult MDD. Thirty-nine investigations met inclusion criteria. MDD-PGS emerged as the most consistently replicated predictor, each standard deviation increase raising…
